Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis.
Autor: | van der Pol MA, Feller N, Ossenkoppele GJ, Weijers GW, Westra AH, van Stijn A, Broxterman HJ, Schuurhuis GJ |
---|---|
Jazyk: | angličtina |
Zdroj: | Leukemia [Leukemia] 2003 Aug; Vol. 17 (8), pp. 1674-7. |
DOI: | 10.1038/sj.leu.2403025 |
Databáze: | MEDLINE |
Externí odkaz: |